WEINSTEIN ROBERT bought PMCB
December 12, 2025 · Form 4 insider transaction
WEINSTEIN ROBERT bought 75,000 shares of PharmaCyte Biotech, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Acquired (buy-side)
Shares
75,000
Price
$0.00
Total value
N/A
InsiderWEINSTEIN ROBERT
Role—
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateDecember 12, 2025
Filing dateDecember 12, 2025
Shares owned after75,000
OwnershipDirect
10b5-1 planNo
AmendedNo